EyePoint Pharmaceuticals (EYPT) Change in Receivables: 2010-2024
Historic Change in Receivables for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to $244,000.
- EyePoint Pharmaceuticals' Change in Receivables rose 21366.10% to $12.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was $15.1 million, marking a year-over-year increase of 1469.06%. This contributed to the annual value of $244,000 for FY2024, which is 101.69% up from last year.
- According to the latest figures from FY2024, EyePoint Pharmaceuticals' Change in Receivables is $244,000, which was up 101.69% from -$14.4 million recorded in FY2023.
- In the past 5 years, EyePoint Pharmaceuticals' Change in Receivables registered a high of $10.6 million during FY2021, and its lowest value of -$14.4 million during FY2023.
- Moreover, its 3-year median value for Change in Receivables was $244,000 (2024), whereas its average is -$3.8 million.
- Per our database at Business Quant, EyePoint Pharmaceuticals' Change in Receivables spiked by 318.80% in 2021 and then plummeted by 642.15% in 2023.
- Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Change in Receivables stood at -$4.8 million in 2020, then soared by 318.80% to $10.6 million in 2021, then tumbled by 74.89% to $2.7 million in 2022, then plummeted by 642.15% to -$14.4 million in 2023, then surged by 101.69% to $244,000 in 2024.